Intellivent Versus Conventional Ventilation
Intellivent
Comparative Monocenter RCT Comparing Safety and Efficacy of an Automated Closed-loop Oxygenation and Ventilation(IntelliVent® System - HAMILTON MEDICAL AG) With Non-automated Conventional Ventilation and Oxygenation
1 other identifier
interventional
80
1 country
1
Brief Summary
Partial automation of mechanical ventilation in resuscitation has been available for several years. New modalities are being developed to completely automate ventilation and oxygenation parameters (IntelliVent®. This pilot study compares over a 48h period the safety and efficacy of IntelliVent®, versus a conventional ventilation modality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Feb 2011
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 11, 2012
CompletedFirst Posted
Study publicly available on registry
April 16, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedDecember 6, 2012
December 1, 2012
1.2 years
April 11, 2012
December 5, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Safety
Safety is assessed by measuring the number of times it is necessary to manually intervene on the ventilator settings because for one the following parameters: A range SpO2, EtCO2, plateau pressure (Pplat), tidal volume (VT), respiratory rate (RR) values considered as non-optimal, as defined a priori and consensually by a panel of experts.
48 Hours
Secondary Outcomes (2)
Efficacy
48 Hours
Care workload
48H
Study Arms (2)
Conventional ventilation
NO INTERVENTIONUsual ventilation is administered according to the protocols implemented in the unit
Intellivent
EXPERIMENTALIntellivent is a ventilatory mode included in ventilator S1, Hamilton Medical. Intervention: the patient is ventilated with the same ventilator than in the conventionnal group; but the "ASV-Intellivent" ventilation has to be activated via a dedicated key on the ventilator screen. IntelliVent® activation requires selecting the kind of patient: ARDS, COPD and whether hemodynamic instability exists. The initial settings are IntelliVent® by default settings (% MV: 110%, PEEP: 5 cm H2O, FiO2: 60% - 100% in case of ARDS). Therefore modification of these various parameters is automatic. FiO2 and PEP are modified according to SpO2; %MV according to EtCO2.
Interventions
Intellivent allows an automatic adjustment of the following parameters: FiO2, PEEP and %VM according to adjusted parameters: Size, SpO2 and EtCO2
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years old
- Patient under invasive ventilation for more than 6 hours and for a planned duration of at least 48 hours
- Body Mass Index (current weight (kg)/height (m)²) \< 40
- Signature of an informed consent by the family
You may not qualify if:
- Need for ventricular assistance with intra-aortic balloon counterpulsation.
- Presence of a bronchopleural fistula
- Pregnant women: A pregnancy blood test will be performed in women of reproductive age. The results will be communicated to the patient by a physician of her choice.
- Adults under guardianship
- People deprived of freedom
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Polyvalent Intensive Care, St Luc Clinics
Brussels, 1200, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre-François Laterre, Pr
Reanimation, Cliniques Universitaires Saint Luc
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2012
First Posted
April 16, 2012
Study Start
February 1, 2011
Primary Completion
April 1, 2012
Study Completion
June 1, 2012
Last Updated
December 6, 2012
Record last verified: 2012-12